^
BIOMARKER:

miR-142 overexpression

i
Other names: MIR142, MicroRNA 142, Hsa-MiR-142-3p, Hsa-MiR-142-5p, Hsa-Mir-142, MIR142, Hsa-Mir-142-V1, Hsa-Mir-142-V2, Hsa-Mir-142-V3, Hsa-Mir-142-V4, MIMAT0000433, MIMAT0000434, MI0000458, MIRN142, Mir-142, RF01896
Entrez ID:
miR-142 overexpression
Ovarian Cancer
bevacizumab
Sensitive: C3 – Early Trials
J Ovarian Res - 2 weeks
miR-142 overexpression
Triple Negative Breast Cancer
paclitaxel
Sensitive: C3 – Early Trials